Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Option Care Health (OPCH) Non-Current Deferred Tax Liability (2016 - 2025)

Option Care Health (OPCH) has disclosed Non-Current Deferred Tax Liability for 17 consecutive years, with $56.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Deferred Tax Liability fell 63.06% year-over-year to $56.0 million, compared with a TTM value of $56.0 million through Dec 2025, down 63.06%, and an annual FY2025 reading of $56.0 million, down 63.06% over the prior year.
  • Non-Current Deferred Tax Liability was $56.0 million for Q4 2025 at Option Care Health, up from $50.0 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $151.6 million in Q4 2024 and bottomed at $4.0 million in Q1 2021.
  • Average Non-Current Deferred Tax Liability over 5 years is $39.0 million, with a median of $35.4 million recorded in 2023.
  • The sharpest move saw Non-Current Deferred Tax Liability soared 334.26% in 2024, then tumbled 63.06% in 2025.
  • Year by year, Non-Current Deferred Tax Liability stood at $4.5 million in 2021, then skyrocketed by 390.24% to $22.2 million in 2022, then skyrocketed by 57.62% to $34.9 million in 2023, then skyrocketed by 334.26% to $151.6 million in 2024, then plummeted by 63.06% to $56.0 million in 2025.
  • Business Quant data shows Non-Current Deferred Tax Liability for OPCH at $56.0 million in Q4 2025, $50.0 million in Q3 2025, and $49.2 million in Q2 2025.